Generic Name: Metformin Hydrochloride 500mg
Manufacturer: Incepta Pharmaceuticals Ltd.
🛒 How to order this item?
100% Genunie Product
Safe & Secure Payment
Secure & Effecient Delivery
Proper Packaging
Show More
Indications
In order to improve glycemic control, patients with type 2 diabetes mellitus who are not adequately controlled on Vildagliptin or Metformin Hydrochloride alone, or who are already receiving treatment with the combination of Vildagliptin and Metformin Hydrochloride as separate tablets, should take this tablet in addition to a healthy diet and regular exercise.
Pharmacology
Vildagliptin acts fundamentally by hindering DPP-4 (Dipeptidyl peptidase-4), the chemical mindful for the debasement of the incretin hormones GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide). The organization of Vildagliptin comes about in a quick and total hindrance of DPP-4 action coming about in expanded fasting and postprandial endogenous levels of the incretin hormones GLP-1 and GIP. By expanding the endogenous levels of these incretin hormones, Vildagliptin increments affront emission from the pancreatic beta-cell and diminishes glucagon discharge from the alpha cell. The improved increment within the insulin/glucagon proportion amid hyperglycemia due to expanded incretin hormone levels comes about in a diminish in fasting and postprandial hepatic glucose generation, driving to reduced glycemia. Metformin Hydrochloride could be a biguanide sort of verbal antihyperglycemic medication utilized within the administration of sort 2 diabetes. It brings down both basal and postprandial plasma.
Dosage & Administration
Metformin immediate-release tablet:
The dosage of Metformin Hydrochloride must be individualized on the basis of both effectiveness and tolerance, while not exceeding the maximum recommended daily doses.
Adult:
Children:
Metformin extended-release tablet:
Adult:
Children:
Renal impaired patient:
Interaction
No clinically pertinent pharmacokinetic interaction was watched when Vildagliptin (100 mg once day by day) was co-administered with Metformin Hydrochloride (1,000 mg once day by day). Vildagliptin incorporates a low potential for sedate intuition. Since Vildagliptin isn't a cytochrome P (CYP) 450 chemical substrate nor does it restrain nor actuate CYP 450 chemicals, it isn't likely to connect with co-medications that are substrates, inhibitors, or inducers of these proteins. As a result of these considers no clinically significant intelligence with other verbal antidiabetics (glibenclamide, pioglitazone, metformin hydrochloride), amlodipine, digoxin, ramipril, simvastatin, valsartan or warfarin were watched after co-administration with vildagliptin. On the other hand, furosemide, nifedipine, and glyburide increment Cmax and blood AUC of Metformin with no alteration in renal clearance of Metformin.
Contraindications
This combination is contraindicated in patients with known touchiness to Vildagliptin or Metformin Hydrochloride or to any of the excipients. It is contraindicated in patients with renal illness or renal brokenness, intense myocardial localized necrosis, and septicemia. It is additionally contraindicated in patients with congestive heart disappointment patients and in patients with intense or inveterate metabolic acidosis, counting diabetic ketoacidosis, with or without coma. It ought to be incidentally suspended in patients experiencing radiologic thinks about including intravascular organization of iodinated differentiate materials, since the utilization of such items may result in an intense change of renal work.
Side Effects
Pregnancy & Lactation
There are no satisfactory and well-controlled ponders in pregnant ladies and so, this combination ought to not be utilized amid pregnancy unless the potential advantage legitimizes the potential chance for the embryo. No ponders have been conducted with the components of this combination. Because it isn't known whether Vildagliptin and/or Metformin Hydrochloride is excreted in the human drain this combination ought to not be managed for breastfeeding ladies.
Precautions & Warnings
There are no satisfactory and well-controlled ponders in pregnant ladies and so, this combination ought to not be utilized amid pregnancy unless the potential advantage legitimizes the potential chance for the embryo. No ponders have been conducted with the components of this combination. Because it isn't known whether Vildagliptin and/or Metformin Hydrochloride is excreted in the human drain this combination ought to not be managed for breastfeeding ladies.
Storage Conditions
Keep in a dry place away from light and heat. Keep out of the reach of children.
Disclaimer:
ePharma sole intention is to ensure that its consumers get proper
information as musch as possible. Although we do not guarantee the
accuracy and the completeness of the information that provided and
here information is for informational purposes only.
The information contained herein should NOT be used as a substitute
for the advice of a qualified physician. This may not cover
everything about particular health conditions,
lab tests, medicines, all possible side effects, drug interactions,
warnings, alerts, etc. Please consult your healthcare professional
and discuss all your queries related to any disease or medicine. We
intend to support, not replace, the doctor-patient relationship.